Chemotherapy counteracted
Authors:
- 1 December 2010
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 468 (7324) , 637-638
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Peering into the aftermath: The inhospitable host?Nature Medicine, 2010
- DNA Damage-Mediated Induction of a Chemoresistant NicheCell, 2010
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cellsCancer Letters, 2010
- Metronomic chemotherapy: new rationale for new directionsNature Reviews Clinical Oncology, 2010
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal CancerCell Stem Cell, 2010
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate CancerClinical Cancer Research, 2010
- Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factorsNature Reviews Cancer, 2010
- Cancer stem cell and nicheFrontiers in Bioscience-Scholar, 2010
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretionNature Cell Biology, 2009
- Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapyCytokine, 2004